Pratama, Anggara Martha and Lorensia, Amelia (2020) Difference Real Costs Compared with INA CBG Rates for Asthma Patients. International Journal of Health, Nursing & Medicine, 6 (2). pp. 11-24. ISSN 2193-3715
Preview |
PDF
Costs-Asthma_2020.pdf Download (1MB) | Preview |
Abstract
Abstract: The cost of treating an asthma attack at the "XYZ" General Hospital, which previously had asthma patients receiving treatment at the emergency room. This study is different from other studies because in addition to describing the direct medical costs, it also recognizes the discrepancy between the real costs of INA-BGS’S rates for asthma in hospitals. The INA-CBG system, the casemix system is a grouping of diagnoses and procedures with reference to similar clinical features and similar treatment costs, grouping is done using a grouper. The research design used in this study is a non-experimental research design with a retrospective method. Retrospective studies are used by following patient medical record data. The sampling technique used in this study was purposive sampling. In this study with a minimum total sample size of 97 people. Based on the results of research related to the real cost analysis compared with the cost of INA CBG'S in asthma patients hospitalized at the Hospital is 1) The average total direct medical costs in grade 1 mild asthma patients is Rp 3,711,753 / patient, grade 2 mild asthma patients in the amount of Rp. 3,451,968 / patient, grade 3 mild asthma patients in the amount of Rp.4,961,418 / patient; 2) The average total direct medical costs for moderate grade 1 asthma patients is Rp 1,912,000 / patient, moderate grade 2 asthma patients are Rp 1,942,512 / patient and no data is found in grade 3 moderate asthma patients; 3) The average total direct medical costs in grade 1 severe asthma patients is Rp 2,100,000 / patient and no data is found in grade 2 and 3 severe asthma patients; 4) The results of data processing from the help of SPSS for Windows version 25 with the independent t-test obtained data that the P value of 0.002 is smaller than the alpha value of 0.05 (P value Value α). It can be concluded that there are significant differences in the total direct medical costs between the Real cost group and the INA CBG's Cost.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | asthma patients, INA-CBG system, similar clinical features and similar treatment costs and average total direct medical costs. |
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | Faculty of Pharmacy > Department of Pharmacy |
| Depositing User: | Ester Sri W. 196039 |
| Date Deposited: | 06 Apr 2020 03:50 |
| Last Modified: | 24 Mar 2021 16:23 |
| URI: | http://repository.ubaya.ac.id/id/eprint/37716 |
Actions (login required)
 |
View Item |
